These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3085699)

  • 21. Aldose reductase in the etiology of diabetic complications: I. Introduction.
    Harrison HE; Stribling D; Armstrong FM; Perkins CM
    J Diabet Complications; 1989; 3(1):6-11. PubMed ID: 2540215
    [No Abstract]   [Full Text] [Related]  

  • 22. Aldose reductase, enzyme or artefact?
    Stribling D; Kador PF
    Prog Clin Biol Res; 1987; 232():309-16. PubMed ID: 3112784
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetic mechanism and structural properties of lens aldose reductase.
    Doughty CC; Lee SM; Conrad S; Schade S
    Prog Clin Biol Res; 1982; 114():223-42. PubMed ID: 6819583
    [No Abstract]   [Full Text] [Related]  

  • 24. Human carbonyl reductases.
    Wermuth B
    Prog Clin Biol Res; 1982; 114():261-74. PubMed ID: 6819584
    [No Abstract]   [Full Text] [Related]  

  • 25. Aldehyde reductases and their involvement in muscular dystrophy.
    Davidson WS; Murphy DG
    Prog Clin Biol Res; 1985; 174():251-63. PubMed ID: 3920676
    [No Abstract]   [Full Text] [Related]  

  • 26. Aldose reductase in the etiology of diabetic complications. 3. Neuropathy.
    Stribling D; Armstrong FM; Perkins CM; Smith JC
    J Diabet Complications; 1989; 3(3):139-48. PubMed ID: 2528557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathobiochemistry of the late-onset diabetic syndrome].
    Wieland OH
    Med Klin; 1974 Sep; 69(36):1417-23. PubMed ID: 4437430
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunohistologic localization of aldose reductase in the human eye by monoclonal antibodies].
    Jahn CE; Schindler E; Holbach L; Kador PF
    Fortschr Ophthalmol; 1984; 81(5):433-5. PubMed ID: 6437949
    [No Abstract]   [Full Text] [Related]  

  • 29. The involvement of aldose reductase in diabetic complications.
    Kinoshita JH; Nishimura C
    Diabetes Metab Rev; 1988 Jun; 4(4):323-37. PubMed ID: 3134179
    [No Abstract]   [Full Text] [Related]  

  • 30. Etiology of cataracts in diabetics.
    Varma SD; Richards RD
    Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
    [No Abstract]   [Full Text] [Related]  

  • 31. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
    Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
    J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation by radioimmunoassay of aldose reductase (ALR2) in normal and diabetic rats.
    McDonald G; Clark AF; Flynn TG
    Prog Clin Biol Res; 1987; 232():367-75. PubMed ID: 3112789
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The activity of xylose reductase and xylitol dehydrogenase in yeasts].
    Iablochkova EN; Bolotnikova OI; Mikhaĭlova NP; Nemova NN; Ginak AI
    Mikrobiologiia; 2003; 72(4):466-9. PubMed ID: 14526534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polyol pathways and complications of diabetes. A new pharmacologic approach].
    Ruetsch YA; Uebersax R
    Rev Med Suisse Romande; 1990 Sep; 110(9):723-30. PubMed ID: 2122510
    [No Abstract]   [Full Text] [Related]  

  • 39. Pig brain aldose reductase: a kinetic study using the centrifugal fast analyzer.
    Boghosian RA; McGuinness ET
    Int J Biochem; 1981; 13(8):909-14. PubMed ID: 6791973
    [No Abstract]   [Full Text] [Related]  

  • 40. [Polyol pathway].
    Nakamura J; Kamiya H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():53-60. PubMed ID: 27266062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.